voriconazole has been researched along with Retinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agard, E; Chehab, HE; Dot, C; Dot, JM; Douma, I; Mounier, A; Vie, AL | 1 |
| Brown, RL; Burke, NS; Duvoisin, RM; Morgans, CW; Reed, B; Xiong, WH | 1 |
2 other study(ies) available for voriconazole and Retinal Diseases
| Article | Year |
|---|---|
Macular toxicity and blind spot enlargement during a treatment by voriconazole: A case report.
Topics: Aged; Antifungal Agents; Electroretinography; Evoked Potentials, Visual; Humans; Macula Lutea; Male; Pulmonary Aspergillosis; Retinal Diseases; Tomography, Optical Coherence; Visual Acuity; Voriconazole | 2018 |
Voriconazole, an antifungal triazol that causes visual side effects, is an inhibitor of TRPM1 and TRPM3 channels.
Topics: Animals; Antifungal Agents; Cells, Cultured; Cricetinae; Dark Adaptation; Disease Models, Animal; Electroretinography; Female; Mice; Retinal Diseases; TRPM Cation Channels; Visual Acuity; Voriconazole | 2015 |